|
1
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Olaku O and White JD: Herbal therapy use
by cancer patients: A literature review on case reports. Eur J
Cancer. 47:508–514. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang CJ, Hsieh YJ, Chu CY, Lin YL and
Tseng TH: Inhibition of cell cycle progression in human leukemia
HL-60 cells by esculetin. Cancer Lett. 183:163–168. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chu CY, Tsai YY, Wang CJ, Lin WL and Tseng
TH: Induction of a poptosis by esculetin in human leukemia cells.
Eur J Pharmacol. 416:25–32. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kuo HC, Lee HJ, Hu CC, Shun HI and Tseng
TH: Enhancement of esculetin on Taxol-induced apoptosis in human
hepatoma HepG2 cells. Toxicol Appl Pharmacol. 210:55–62. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Leung KN, Leung PY, Kong LP and Leung PK:
Immunomodulatory effects of esculetin (6,7-dihydroxycoumarin) on
murine lymphocytes and peritoneal macrophages. Cell Mol Immunol.
2:181–188. 2005.PubMed/NCBI
|
|
8
|
Kaneko T, Tahara S and Takabayashi F:
Inhibitory effect of natural coumarin compounds, esculetin and
esculin, on oxidative DNA damage and formation of aberrant crypt
foci and tumors induced by 1,2-dimethylhydrazine in rat colons.
Biol Pharm Bull. 30:2052–2057. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Noguchi M, Earashi M, Minami M, Miyazaki
I, Tanaka M and Sasaki T: Effects of piroxicam and esculetin on the
MDA-MB-231 human breast cancer cell line. Prostaglandins Leukot
Essent Fatty Acids. 53:325–329. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Effect of esculetin on proliferation of
human heptocellular carcinoma cell line SMMC-7721 in vitro. Chin
JMAP. 26:6439–442. 2009.
|
|
11
|
Din FV, Theodoratou E, Farrington SM,
Tenesa A, Barnetson RA, Cetnarskyj R, Stark L, Porteous ME,
Campbell H and Dunlop MG: Effect of aspirin and NSAIDs on risk and
survival from colorectal cancer. Gut. 59:1670–1679. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tavazoie SF, Alarcón C, Oskarsson T, Padua
D, Wang Q, Bos PD, Gerald WL and Massagué J: Endogenous human
microRNAs that suppress breast cancer metastasis. Nature.
451:147–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Miyoshi K and Hennighausen L:
Beta-catenin: A transforming actor on many stages. Breast Cancer
Res. 5:63–68. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Maruyama K, Ochiai A, Akimoto S, Nakamura
S, Baba S, Moriya Y and Hirohashi S: Cytoplasmic beta-catenin
accumulation as a predictor of hematogenous metastasis in human
colorectal cancer. Oncology. 59:302–309. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Polakis P: Wnt signaling and cancer. Genes
Dev. 14:1837–1851. 2000.PubMed/NCBI
|
|
16
|
Koehler A, Schlupf J, Schneider M, Kraft
B, Winter C and Kashef J: Loss of Xenopus cadherin-11 leads to
increased Wnt/beta-catenin signaling and up-regulation of target
genes c-myc and cyclin D1 in neural crest. Dev Biol. 383:132–145.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lim SC and Lee MS: Significance of
E-cadherin/β-catenin complex and cyclin D1 in breast cancer. Oncol
Rep. 9:915–928. 2002.PubMed/NCBI
|
|
18
|
Roh MS, Hong SH, Jeong JS, Kwon HC, Kim
MC, Cho SH, Yoon JH and Hwang TH: Gene expression profiling of
breast cancers with emphasis of beta-catenin regulation. J Korean
Med Sci. 19:275–282. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Utsuki S, Sato Y, Oka H, Tsuchiya B,
Suzuki S and Fujii K: Relationship between the expression of E-,
N-cadherins and beta-catenin and tumor grade in astrocytomas. J
Neurooncol. 57:187–192. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ehrlich D, Bruder E, Thome MA, Gutt CN,
von Knebel Doeberitz M, Niggli F, Perantoni AO and Koesters R:
Nuclear accumulation of beta-catenin protein indicates activation
of wnt signaling in chemically induced rat nephroblastomas. Pediatr
Dev Pathol. 13:1–8. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu Y, Wang S, Wu X, Zhang J, Chen R, Chen
M and Wang Y: Chinese herbal medicine-derived compounds for cancer
therapy: A focus on hepatocellular carcinoma. J Ethnopharmacol.
149:601–612. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu YZ, Wu K, Huang J, Liu Y, Wang X, Meng
ZJ, Yuan SX, Wang DX, Luo JY, Zuo GW, et al: The PTEN/PI3K/Akt and
Wnt/β-catenin signaling pathways are involved in the inhibitory
effect of resveratrol on human colon cancer cell proliferation. Int
J Oncol. 45:104–112. 2014. View Article : Google Scholar : PubMed/NCBI
|
